A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers

查看全文 作　　者：Matthew;G.;Fury;Andrew;Zahalsky;Richard;Wong;Ennapadam;Venkatraman;Eric;Lis;Lucy;Hann;Timothy;Aliff;William;Gerald;Martin;Fleisher;David;G.;Pfister 出　　处：《Investigational New Drugs》索引2007年第2期,共0页